JW Pharmaceutical Corp (001065) — Cash Flow Quality Index
JW Pharmaceutical Corp (001065) has a Cash Flow Quality Index of 1.53x as of September 2025. Operating cash flow of ₩46.92 Billion exceeds net income of ₩30.59 Billion, indicating high earnings quality where cash backs reported profits. Explore 001065 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
JW Pharmaceutical Corp Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for JW Pharmaceutical Corp across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check JW Pharmaceutical Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for JW Pharmaceutical Corp (2015–2024)
Year-by-year earnings quality comparison for JW Pharmaceutical Corp. For live market cap and the full company financial profile, see JW Pharmaceutical Corp (001065) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | — |